[Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)]

Rofo. 2014 Jun;186(6):615-7. doi: 10.1055/s-0033-1356047. Epub 2013 Dec 17.
[Article in German]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cytarabine / adverse effects
  • Cytarabine / therapeutic use
  • Daunorubicin / adverse effects
  • Daunorubicin / therapeutic use
  • Diagnosis, Differential
  • Dyspnea / chemically induced*
  • Dyspnea / diagnostic imaging
  • Female
  • Follow-Up Studies
  • Humans
  • Induction Chemotherapy*
  • Leukemia, Promyelocytic, Acute / diagnostic imaging
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Middle Aged
  • Mitoxantrone / adverse effects
  • Mitoxantrone / therapeutic use
  • Pleural Effusion / chemically induced*
  • Pleural Effusion / diagnostic imaging
  • Pulmonary Edema / chemically induced*
  • Pulmonary Edema / diagnostic imaging
  • Thioguanine / adverse effects
  • Thioguanine / therapeutic use
  • Tomography, X-Ray Computed
  • Tretinoin / administration & dosage*
  • Tretinoin / adverse effects*

Substances

  • Cytarabine
  • Tretinoin
  • Mitoxantrone
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1
  • MAC chemotherapy protocol